HMC+ Exit

Production of chitin and chitosan-based high purity biopolymers. HMC develops new chitosan applications for the pharmaceutical industry, nanoparticles for drug delivery systems, and is a custom manufacturer of chitosan derivatives.

Press releases

Second financing round for Heppe Medical Chitosan GmbH with KI Kapital and High-Tech Gründerfonds

The latest investment will be used by Heppe Medical Chitosan GmbH (HMC+) to enlarge the marketing and sales force worldwide. HMC+ is an innovative developer and producer of pure biopolymers and nanoparticles based on chitin and chitosan. Heppe Medical Chitosan GmbH produces pure chitin, chitosan und derivates for the…

Info & Contact


Heinrich-Damerow-Straße 1
06120 Halle (Saale)

In portfolio

03. Jun 2008 – 23. Jun 2020